Abstract
Recently, bioinspired cell-derived nanovesicles (CDNs) have gained much interest in the field of nanomedicine due to the preservation of biomolecular structure characteristics derived from their parent cells, which impart CDNs with unique properties in terms of binding and uptake by target cells and intrinsic biological activities. Although the production of CDNs can be easily and reproducibly achieved with any kind of cell culture, application of CDNs for therapeutic purposes has been greatly hampered by their physical and chemical instability during long-term storage in aqueous dispersion. In the present study, we conceived a lyophilization approach that would preserve critical characteristics regarding stability (vesicles’ size and protein content), structural integrity, and biological activity of CDNs for enabling long-term storage in freeze-dried form. Compared to the lyoprotectant sucrose, trehalose-lyoprotected CDNs showed significantly higher glass transition temperature and lower residual moisture content. As assessed by ATR-FTIR and far-UV circular dichroism, lyophilization in the presence of the lyoprotectant effectively maintained the secondary structure of cellular proteins. After reconstitution, lyoprotected CDNs were efficiently associated with HeLa cells, CT26 cells, and bone marrow-derived macrophages at a rate comparable to the freshly prepared CDNs. In vivo, both lyoprotected and freshly prepared CDNs, for the first time ever reported, targeted the injured heart, and exerted intrinsic cardioprotective effects within 24 h, attributable to the antioxidant capacity of CDNs in a myocardial ischemia/reperfusion injury animal model. Taken together, these results pave the way for further development of CDNs as cell-based therapeutics stabilized by lyophilization that enabled long-term storage while preserving their activity.
Highlights
In the field of nanomedicine, nanovesicles derived from cells of various origin have been explored for their potential as drug delivery systems [1,2], diagnostic probes [3], and cell-based therapeutics [4,5,6,7]
We demonstrated that cell-derived nanovesicles (CDNs) were taken up intracellularly and were not confined/adsorbed onto the cellular plasma membranes through confocal laser scanning microscopy analysis (Supplementary Figure S6), which was performed on fluorescently labeled U937 cell-derived CDNs, sucrose-lyoprotected CDNs (S1), trehaloselyoprotected CDNs (T1), non-lyoprotected CDNs (W), and heat-denatured CDNs (H)
As U937 monocytic cell-derived exosomes were reported to carry several antioxidant enzymes (AOEs, namely SOD1, SOD2, catalase, GSTK1, and PRDX6) inherited from parent cells [12], we examined if lyophilization affected the antioxidant capacity of CDNs due to the presence of those antioxidant enzymes derived from U937 cells
Summary
In the field of nanomedicine, nanovesicles derived from cells of various origin have been explored for their potential as drug delivery systems [1,2], diagnostic probes [3], and cell-based therapeutics (i.e., with intrinsic pharmacological effects) [4,5,6,7]. The advantages of these naturally occurring vesicles (e.g., extracellular vesicles like exosomes) over their conventional counterparts (e.g., liposomes) include a lowered immunogenicity and innate targeting abilities, enabling them to be recognized and efficiently internalized by target cells [8,9,10]. CDNs can be prepared from any type of cell using simple, scalable, and cost-effective production processes [11,13]
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
